ORTHOFIX INTERNATIONAL NV (OFIX:NASDAQ)
Orthofix International, N.V. is a global medical device company offering a broad line of minimally invasive surgical, and non-surgical, products for the spine, orthopedic, and sports medicine market sectors that address the lifelong bone-and-joint health needs of patients of all ages–helping them achieve a more active and mobile lifestyle. Orthofix’s products are widely distributed around the world to orthopedic surgeons and patients via Orthofix’s sales representatives and its subsidiaries, including BREG, Inc. and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&D activities with leading medical institutions such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, The University of Medicine and Dentistry of New Jersey and the National Osteoporosis Institute.
Yearly Figures
| (in thousands, except per share amounts) |
| FYE: 12/31 |
2009 |
2008 |
2007 |
2006 |
| Net Revenues |
$545,635 |
$519,675 |
$490,323 |
$365,359 |
| Net Income |
24,472 |
(228,554) |
10,968 |
(7,042) |
| Earnings Per Share |
1.42 |
(13.37) |
0.64 |
(0.44) |
Quarterly Figures
| (in thousands, except per share amounts) |
| | Second Quarter |
| FYE: 12/31 |
6/30/10 |
6/30/09 |
| Net Revenues |
$142,845 |
$137,546 |
| Net Income |
10,232 |
5,944 |
| Earnings Per Share |
0.57 |
0.35 |
|
